The U.S. Court of Appeals for the Federal Circuit on Friday
declined to reconsider its decision for Askeladden, the
patent-litigation subsidiary of a consortium of 25 large banks,
in a challenge to Verify Smart Corp’s patent on multifactor
authentication for electronic-banking transactions.
The Biotechnology Innovation Organization on Tuesday urged
the U.S. Court of Appeals for the Federal Circuit to grant en
banc review of a panel decision that invalidated six patents on
Amarin Pharma’s leading product, Vascepa, and opened the door to
generic competition by Hikma Pharmaceuticals and Dr. Reddy’s
A law that bars retaliation against automotive workers for
reporting motor-vehicle defects did not protect a GM
quality-control mechanic who reported that his co-workers had
falsely certified that they had repaired those defects, a
divided appeals court held Thursday.
A divided federal appeals court on Wednesday revived DaVita
Inc’s lawsuit against an employee-benefits health plan and its
administrator, alleging that they discriminate against dialysis
centers and patients with end-stage renal disease (ESRD) in an
effort to get the patients to switch to Medicare.
New Jersey-based Formosa Plastics USA and its Texas
subsidiary sued Chubb’s ACE American Insurance unit on Tuesday,
alleging the insurer breached its pollution-liability policy by
refusing to cover Formosa’s $50 million settlement with the San
Antonio Bay Estuarine Waterkeeper in Texas last year.
The 2nd U.S. Circuit Court of Appeals will hear argument
Wednesday in a case involving a university’s duties to
retirement-plan participants as well as a judge’s duties to
litigants once she decides to return to private practice.
A federal appeals court had harsh words for both sides
Wednesday in a patent-infringement case involving a portable
antenna positioner, saying the parties jointly led the district
court “down a wrong, and possibly unnecessary, path” with
“confusing and potentially meritless theories” and “critical
omissions” about the facts and an absent party.
A woman who convinced Aetna to reimburse her $64.32 for
prescription drug purchases is entitled to $15,000 in attorneys’
fees, but not the additional benefits or $111,000 in fees she
sought, U.S. District Judge Richard Andrews ruled Monday in
A claim of trademark counterfeiting, like a claim of
trademark infringement, requires the accuser to show a
likelihood of confusion between the two products, the 9th U.S.
Circuit Court of Appeals held Thursday in a case of first
impression for the circuit.
A federal judge in California on Wednesday let two chemical
companies move ahead with their lawsuit accusing United National
Insurance Company of breaching its duty to defend them in
environmental litigation with the city of Los Angeles by
refusing to pay their chosen attorneys at Latham & Watkins.